Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02701829 · ClinicalTrials.gov registry record · NA

Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
166
Enrollment target

NCT02701829: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02701829 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02701829, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
166 participants
Enrollment target

Study Summary

In our past work it was found that many drivers had high blood pressure, and lifestyles that led to being overweight and not having cancer screenings performed. The investigators are now adding to the Health Fairs' usual program different ways of following up with drivers who attend our Health Fairs. The investigators are doing this because they want to find the best way to help drivers manage high blood pressure, and reduce cancer risk, by maintaining a healthy weight and increasing colorectal cancer screening. Health screenings will be conducted by trained personnel, and a physician or nurse will provide a health consult in person or over the phone (via MSK-issued phone/video/audio devices). In the event that participants are unable to meet in person for biometric measurements, staff will accept their self-reported weight, blood pressure, and waist circumference over the phone. Staff may mail blood pressure machines (to participants who did not receive them at baseline), scales, and measuring tapes to participants to assist in the completion of self-reported biometric measures. Along with supplies, participants may also receive a letter asking for the confirmation of supply receipt. \* If critically abnormal values are identified during the health fair, under the advisement of the clinician, the driver may be escorted by trained staff directly to a health care facility for immediate medical follow-up

Interventions

  • OTHER CONTROL- Usual & Customary Health Fair Follow-up
  • OTHER Health Fair + TECH [Text Messaging + Home Blood Pressure Monitoring]
  • OTHER Heal th Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] + Social Network Support (SNS)

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2016-02
Est. Completion 2025-10-27
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT02701829

The ClinicalTrials.gov registry entry for NCT02701829 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which CONTROL- Usual & Customary Health Fair Follow-up is the first listed.

NCT02701829 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02701829 about?

NCT02701829 is a clinical study titled "Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support". In our past work it was found that many drivers had high blood pressure, and lifestyles that led to being overweight and not having cancer screenings performed. The investigators are now adding to the Health Fairs' usual program different ways of following up with drivers who attend our Health Fairs...

What is the current status of trial NCT02701829?

This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2016-02. Estimated completion is 2025-10-27.

What interventions are being tested in trial NCT02701829?

The interventions under investigation include: CONTROL- Usual & Customary Health Fair Follow-up (OTHER), Health Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] (OTHER), Heal th Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] + Social Network Support (SNS) (OTHER).

Who is sponsoring clinical trial NCT02701829?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.